Perry Cook, MD, reviews the case of a 76-year-old man with relapsed/refractory follicular lymphoma and provides a discussion on treatment considerations and challenges.
EP. 1: Case Presentation: A 76-Year-Old Man With Relapsed/Refractory Follicular Lymphoma
Perry Cook, MD, presents the case of a 76-year-old man with relapsed/refractory follicular lymphoma.
EP. 2: First-Line Treatment Options for Follicular Lymphoma
A key opinion leader explains the first-line treatment options for follicular lymphoma and the challenges of treating patients with early disease progression.
EP. 3: The Role of Tazemetostat in Relapsed Refractory Follicular Lymphoma
A hematologist/oncologist discusses the tazemetostat as a treatment option for patients with relapsed/refractory follicular lymphoma.
EP. 4: Molecular Testing in Follicular Lymphoma
Perry Cook, MD, reviews the role of molecular testing and biomarkers in treatment selection in patients with follicular lymphoma.
EP. 5: Treatment Considerations for Second-Line Therapy in Follicular Lymphoma
A hematologist/oncologist provides insights on individualizing second-line therapy for patients with relapsed/refractory follicular lymphoma.
EP. 6: Treatment Selection for Later-Line Therapies in Follicular Lymphoma
Dr Perry Cook discusses the challenges of treating relapsed/refractory follicular lymphoma in later lines and describes ongoing developments in the treatment landscape.
2 Clarke Drive Cranbury, NJ 08512